Structure |
Chemical Name |
CAS |
MF |
|
Canagliflozin Impurity 70 |
|
|
|
Dapoxetine impurity 66 |
|
|
|
Gadobutrol Impurity 3 |
|
|
|
Empagliflozin Impurity 84 |
|
|
|
Iohexol Impurity O |
|
|
|
(2,5-dichlorophenyl)(4-ethoxyphenyl)methanone |
1097076-93-1 |
C15H12Cl2O2 |
|
Lenvatinib impurity LFZZ-10 |
|
C11H8Cl2N2O2 |
|
(2S,5S)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate |
|
|
|
Febuxostat Impurity 98 |
|
|
|
(2-(methyl((vinyloxy)carbonyl)amino)pyridin-3-yl)methyl 2-(methylamino)acetate hydrochloride |
|
|
|
1-(4-bromo-3,5-dimethoxyphenyl)ethanone |
1333472-28-8 |
C10H11BrO3 |
|
Ticagrelor Impurity 117 |
|
|
|
Ticagrelor Impurity 136 |
|
|
|
Phenol, 2-(diphenylmethyl)-5-methyl- |
411239-19-5 |
C20H18O |
|
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-3-(1-ethylpropoxy)-5-(formylamino)-, ethyl ester, (3R,4R,5S)- |
2148317-96-6 |
C17H28N2O5 |
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(5-chloro-2-ethoxyphenyl)-5-methyl-7-propyl- |
2245167-80-8 |
C17H19ClN4O2 |
|
Posaconazole impurity 18 |
1819334-66-1 |
C44H49F2N8O4+ |
|
(4S,6R)-6-(2-(tert-butoxy)-2-oxoethyl)-2,2-dimethyl-1,3-dioxane-4-carboxylic acid |
2095786-11-9 |
C13H22O6 |
|
Crisaborole intermediate |
2354382-27-5 |
C14H8BCl2NO3 |
|
Ropivacaine Impurity 48 |
|
|
|
2(3H)-Furanone, dihydro-4-(1-methylethyl)-, (4S)- |
53657-15-1 |
C7H12O2 |
|
Crisaborole Impurity 9 HCl |
1187187-01-4 |
C14H15BClNO3 |
|
2H-Indol-2-one, 3-[[3,5-dimethyl-4-(1-pyrrolidinylcarbonyl)-1H-pyrrol-2-yl]methylene]-5-fluoro-1,3-dihydro- |
2135339-43-2 |
C20H20FN3O2 |
|
Nicergoline Impurity 02 |
|
|
|
Bromhexine ImpurityABCDEFGHJKL |
|
|
|
1-Butanone, 1-(4-fluorophenyl)-4-[(6bR,10aR)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]- |
1576240-16-8 |
C24H28FN3O |
|
impurity 37 |
|
|
|
sodium (6R,7S)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(((5-methyl- 1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
|
|
1,4,7,10-Tetraazacyclododecane-1,4-diacetic acid |
229312-34-9 |
C12H24N4O4 |
|
Pentanoic acid, 3-(bromomethyl)-4-methyl-, ethyl ester, (3S)- |
2432911-38-9 |
C9H17BrO2 |
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[5-[(4-ethyl-1-piperazinyl)sulfonyl]-2-hydroxyphenyl]-5-methyl-7-propyl- |
2411340-39-9 |
C21H28N6O4S |
|
3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-[7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-1H-pyrazol-1-yl]- |
1187595-89-6 |
C17H19N7O3S |
|
4-methyl-N-(2-(methylamino)phenyl)-2-propyl-1H-benzo[d]imidazole-6-carboxamide |
884330-18-1 |
C19H22N4O |
|
2,4(1H,3H)-Pyrimidinedione, 5-(2-fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3-[(2R)-2-(hydroxyamino)-2-phenylethyl]-6-methyl- |
2486454-64-0 |
C28H24F5N3O4 |
|
3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-hydroxyphenyl)amino]-6-hydroxy-7-[3-(4-methyl-1-piperazinyl)propoxy]- |
2468737-94-0 |
C24H25Cl2N5O3 |
|
1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, 2,3,6b,7,8,9,10,10a-octahydro-, (6bR,10aS)- |
313368-81-9 |
C13H17N3 |
|
Ergoline-8-methanol, 1,6-dimethyl-, (8β)- (9CI) |
40170-12-5 |
C17H22N2O |
|
Cisatracurium besylate impurity 16 |
|
|
|
1-ACETYL-2-METHYLBENZIMIDAZOLE |
14678-81-0 |
C10H10N2O |
|
(E)-3-(2-Formylphenyl)-2-propenoic acid 1,1-dimethyl ethyl ester |
103890-69-3 |
C14H16O3 |
|
Bimatoprost Impurity 22 |
|
|
|
Bumetanide Impurity 9 |
|
|
|
Crisaborole Impurity 14 |
|
|
|
Benzonitrile, 4-[(1E)-4-(dimethylamino)-1-(4-fluorophenyl)-1-buten-1-yl]-3-(hydroxymethyl)- |
1370643-23-4 |
C20H21FN2O |
|
Latamoxef impurity B |
|
|
|
(9alpha,13alpha,14alpha)-3-methoxymorphinan-17-carbaldehyde |
28973-48-0 |
C18H23NO2 |
|
3-(7,8-dimethoxy-2-oxo-1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)-N-(((S)-3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)-N-methylpropan-1-amine oxide |
2511244-97-4 |
C27H36N2O6 |
|
Labetalol EP Impurity I |
|
|
|
Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-chloro-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl- |
2443747-63-3 |
C19H20BrClN6O4S |
|
Methyl-3-oxo1,2-benzisothiazol-2(3H)-acetat-1,1-dioxid |
6639-62-9 |
C10H9NO5S |
|
(6R-cis)-3-(Hydroxymethyl)-7-methoxy-8-oxo-7-(2-thienylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carbonsure |
54333-94-7 |
C15H16N2O6S2 |
|
5-Acetyl-1,3-phenylenbis(dimethylcarbamat) |
81732-48-1 |
C14H18N2O5 |
|
Oseltamivir Impurity L |
|
|
|
1,4-Naphthalenediol, 2-methyl-, 4-acetate |
110327-29-2 |
C13H12O3 |
|
Oseltamivir Impurity 105 |
|
|
|
Oseltamivir Impurity 77 |
|
|
|
Imidapril Impurity 2 |
|
|
|
Betamethasone EP Impurity G |
85700-75-0 |
C22H30O5 |
|
Crisaborole Impurity ABCDEFGHJKL |
|
|
|
3-Azetidinecarboxylic acid, 1-[(4-acetyl-2-ethylphenyl)methyl]- |
2474774-17-7 |
C15H19NO3 |
|
2,3'-Bipyridine, 5-chloro-3-[4-(methylsulfonyl)phenyl]-, hydrochloride (1:1) |
202409-39-0 |
C17H14Cl2N2O2S |
|
1,1'-((methylenebis(4-methoxy-3,1-phenylene))bis(2-(dimethylamino)ethane-1,1-diyl))dicyclohexanol |
|
|
|
2-amino-4-(2-(benzyl(1-(4-methoxyphenyl)propan-2-yl)amino)-1-hydroxyethyl)phenol |
|
|
|
Peramivir Deacetyl Impurity |
|
|
|
Empagliflozin Impurity 116 |
|
|
|
(3R,5aS)-5,8-dioxooctahydro-5H-pyrrolo[1,2-a]thiazolo[3,2-d]pyrazine-3-carboxylic acid |
|
|
|
Phospholipid Impurity 1(DPPE-MPEG5000 Impurity 1) |
|
|
|
Carbazochrome Sodium Sulfonate Impurity 4 |
|
|
|
Empagliflozin Furanose Impurity |
|
|
|
Rosuvastatin Impurity 144 |
|
|
|
Cetrorelix Impurity 11 |
|
|
|
Cetrorelix Impurity 4 (8-D-Arg) |
|
|
|
Cetrorelix Impurity 1 (+L-Arg) |
|
|
|
Peramivir Intermediate Impurity 36 |
|
|
|
Peramivir Intermediate Impurity 41 |
|
|
|
Peramivir Impurity 999 |
|
|
|
Palonosetron impurity 20XH |
|
|
|
Levofloxacin benzopazine impurity |
|
|
|
Bumetanide Impurity 14 |
1431501-10-8 |
C21H27NO3 |
|
Trans,rel-(1R,4R)-4-{[(2-Aminophenyl)methyl]amino}cyclohexan-1-ol Hydrochloride |
|
|
|
Sugammadex Sodium Impurity 08 |
|
|
|
2-bromo-3-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile |
|
|
|
INDEX NAME NOT YET ASSIGNED |
2412953-12-7 |
C72H112O49S8 |
|
4a(2H)-Isoquinolinol, octahydro-4-(4-methoxyphenyl)-2-methyl- |
2568340-30-5 |
C17H25NO2 |
|
3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-hydroxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]- |
2468737-92-8 |
C25H27Cl2N5O3 |
|
Uridine, 4-oxime, 5'-(2-methylpropanoate), (4E)- |
2492423-30-8 |
C13H19N3O7 |
|
Empagliflozin Furanose Impurity |
|
|
|
Tazobactam Impurity XTE |
|
|
|
Isavuconazole Impurity 46 |
|
|
|
5-(1-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-2-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one |
2226428-25-5 |
C24H28N2O3 |
|
INDEX NAME NOT YET ASSIGNED |
2740235-22-5 |
C13H22N2O5 |
|
2-(4-ethylpiperazin-1-yl)-4-(2-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine |
|
C23H30FN3 |
|
1-Naphthalenamine, 4-(2,3-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1R,4S)-rel- |
2184053-08-3 |
C17H17Cl2N |
|
Rosuvastatin Impurity 152 |
|
|
|
1-[4-(2-AZEPAN-1-YL-ETHOXY)-BENZYL]-5-BENZYLOXY-2-(4-BENZYLOXY-PHENYL)-3-METHYL-1H-INDOLE |
198480-21-6 |
C44H46N2O3 |
|
6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, 1,1-dimethylethyl ester, (3S,5R,6E)- |
2273873-66-6 |
C29H32FNO4 |
|
2H-1,4-Benzoxazin-3(4H)-one, 8-(2-chloro-1-hydroxyethyl)-6-(phenylmethoxy)- |
2383660-53-3 |
C17H16ClNO4 |
|
Isavuconazole Impurity 40 |
|
|
|
(2R,3S,4R,5R,6S)-2-((R)-1,2-dihydroxyethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triol |
|
|
|
2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-, 1,1'-dioxide |
2724840-93-9 |
C18H15ClN2O4S |